An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223

BACKGROUND: Baseline clinical variables are prognostic for overall survival (OS) in patients with castration-resistant prostate cancer (CRPC). Their prognostic and predictive value with agents targeting bone metastases, such as radium-223, is not established. PATIENTS AND METHODS: The radium-223 ALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartor, O., Coleman, R. E., Nilsson, S., Heinrich, D., Helle, S. I., O’Sullivan, J. M., Vogelzang, N. J., Bruland, Ø., Kobina, S., Wilhelm, S., Xu, L., Shan, M., Kattan, M. W., Parker, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406754/
https://www.ncbi.nlm.nih.gov/pubmed/28453701
http://dx.doi.org/10.1093/annonc/mdx044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406754/
https://www.ncbi.nlm.nih.gov/pubmed/28453701
http://dx.doi.org/10.1093/annonc/mdx044

Ejemplares similares